Literature DB >> 21905782

Tuberculous optochiasmatic arachnoiditis: a devastating form of tuberculous meningitis.

Ravindra Kumar Garg1, Vimal Paliwal, Hardeep Singh Malhotra.   

Abstract

Tuberculous meningitis is primarily a disease of the meninges of brain and spinal cord along with adjacent brain parenchyma. The characteristic pathological changes are meningeal inflammation, basal exudates, vasculitis and hydrocephalus. Tuberculous meningitis has a strong predilection for basal parts of the brain. Exudates, if dominantly present in the interpeduncular, suprasellar and Sylvian cisterns, result in optochiasmatic arachnoiditis and tuberculoma. Optochiasmatic arachnoiditis and tuberculoma are devastating forms of tuberculous meningitis and often associated with profound vision loss. This clinical entity more frequently affects young adults. In a recent study, on the multivariate logistic regression analysis, female sex, younger age and raised cerebrospinal fluid protein content were identified as predictors for developing optochiasmatic arachnoiditis. Frequently, optochiasmatic tuberculoma and optochiasmatic arachnoiditis develop paradoxically while a patient is being treated with anti-TB drugs. MRI reveals confluent enhancing lesions that are present in the interpeduncular fossa, pontine cistern, and the perimesencephalic and suprasellar cisterns. Management of tuberculous optochiasmatic arachnoiditis and optochiasmatic arachnoiditis tuberculoma has been variable. Treatment of optochiasmatic arachnoiditis continues to be a challenge and the response is generally unsatisfactory. In isolated case reports and in small series, corticosteroids, methyl prednisolone, thalidomide and hyaluronidase have been used with variable success. The benefit from neurosurgery is controversial and deterioration may follow the initial temporary improvement. Management of paradoxical optochiasmatic arachnoiditis is also controversial. Some patients regain vision following treatment with anti-TB drugs and continued usage of corticosteroids. Neurosurgery may be considered in the patients with either treatment failure or when diagnosis is in doubt. In conclusion, presence of optochiasmatic arachnoiditis or tuberculoma has important therapeutic and prognostic implications for patients of tuberculous meningitis.

Entities:  

Mesh:

Year:  2011        PMID: 21905782     DOI: 10.1586/eri.11.93

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  8 in total

Review 1.  Non-compressive disorders of the chiasm.

Authors:  Valerie A Purvin; Aki Kawasaki
Journal:  Curr Neurol Neurosci Rep       Date:  2014-07       Impact factor: 5.081

Review 2.  A 43-year systematic review and meta-analysis: case-fatality and risk of death among adults with tuberculous meningitis in Africa.

Authors:  Yohannes W Woldeamanuel; Belaineh Girma
Journal:  J Neurol       Date:  2013-08-21       Impact factor: 4.849

Review 3.  Neuro-ophthalmic manifestations of tuberculosis.

Authors:  Rebika Dhiman; Subodh Lakra; Prateek Kumar Panda; Naren Hemachandran; Sanjay Sharma; Rohit Saxena
Journal:  Eye (Lond)       Date:  2021-06-14       Impact factor: 3.775

4.  Tuberculous optochiasmatic arachnoiditis.

Authors:  Rajesh Verma; Tushar B Patil; Rakesh Lalla
Journal:  J Glob Infect Dis       Date:  2014-04

5.  Management of paradoxical response in pediatric tubercular meningitis with methylprednisolone.

Authors:  Nitin Nema; Abha Verma; Kuldeep Singh; Virendra Mehar
Journal:  Middle East Afr J Ophthalmol       Date:  2014 Apr-Jun

Review 6.  Nonsurgical therapy for hydrocephalus: a comprehensive and critical review.

Authors:  Marc R Del Bigio; Domenico L Di Curzio
Journal:  Fluids Barriers CNS       Date:  2016-02-05

7.  Medical management of acute loss of vision in tuberculous meningitis: A case report.

Authors:  Maryam Amour; Sarah Shali Matuja; Jerome H Chin
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2020-01-18

8.  Intracisternal tuberculoma: a refractory type of tuberculoma indicating surgical intervention.

Authors:  Fanfan Chen; Lei Chen; Yongfu Cao; Yongjun Yi; Jingwen Zhuang; Wuhua Le; Wei Xie; Lanbo Tu; Peng Li; Yimin Fang; Ling Li; Yuqing Kou; Kaikai Fu; Hua He; Hongbin Ju
Journal:  BMC Neurol       Date:  2018-01-18       Impact factor: 2.474

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.